Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.

  • Christina Fotopoulou
  • Rongyu Zang
  • Murat Gultekin
  • David Cibula
  • Ali Ayhan
  • Dongli Liu
  • Rolf Richter
  • Ioana Braicu
  • Sven Mahner
  • Philipp Harter
  • Fabian Trillsch
  • Sanjeev Kumar
  • Michele Peiretti
  • Sean C Dowdy
  • Angelo Maggioni
  • Claes Trope
  • Jalid Sehouli

Related Research units

Abstract

The value of surgery for recurrent epithelial ovarian cancer (OC) is controversial. The aim of the present study was to evaluate the outcome of EOC-patients who underwent tertiary cytoreductive surgery (TCS) and to identify prognostic markers for complete tumor resection and survival.

Bibliographical data

Original languageEnglish
Article number4
ISSN1068-9265
Publication statusPublished - 2013
pubmed 23054114